Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death

Glucocorticoids (GCs) and cAMP-dependent signaling pathways exert diverse and relevant immune regulatory functions, including a tight control of T cell death and homeostasis. Both of these signaling molecules inhibit TCR-induced cell death and FasL expression, but the underlying mechanisms are still...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liberman, Ana, Refojo, Damián
Publicado: 2012
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01615890_v50_n4_p220_Liberman
http://hdl.handle.net/20.500.12110/paper_01615890_v50_n4_p220_Liberman
Aporte de:
id paper:paper_01615890_v50_n4_p220_Liberman
record_format dspace
spelling paper:paper_01615890_v50_n4_p220_Liberman2023-06-08T15:13:30Z Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death Liberman, Ana Refojo, Damián Activation-induced cell death CAMP Chromatin FasL Glucocorticoids NF-κB cyclic AMP cyclic AMP dependent protein kinase dexamethasone Fas ligand genomic DNA glucocorticoid immunoglobulin enhancer binding protein mitogen activated protein kinase T lymphocyte receptor animal cell article cell death mouse nonhuman priority journal protein expression signal transduction transient transfection Animals Apoptosis Blotting, Western Cell Death Cell Separation Cyclic AMP Fas Ligand Protein Flow Cytometry Glucocorticoids Humans Hybridomas Jurkat Cells Lymphocyte Activation Mice Promoter Regions, Genetic Receptors, Antigen, T-Cell Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Transfection Glucocorticoids (GCs) and cAMP-dependent signaling pathways exert diverse and relevant immune regulatory functions, including a tight control of T cell death and homeostasis. Both of these signaling molecules inhibit TCR-induced cell death and FasL expression, but the underlying mechanisms are still poorly understood. Therefore, to address this question, we performed a comprehensive screening of signaling pathways downstream of the TCR, in order to define which of them are targets of cAMP- and GC-mediated inhibition. We found that cAMP inhibited NF-κB and ERK pathways through a PKA-dependent mechanism, while Dexamethasone blocked TCR-induced NF-κB signaling. Although GCs and cAMP inhibited the induction of endogenous FasL mRNA expression triggered by TCR activation, they potentiated TCR-mediated induction of FasL promoter activity in transient transfection assays. However, when the same FasL promoter was stably transfected, the facilitatory effect of GCs and cAMP became inhibitory, thus resembling the effects on endogenous FasL mRNA expression. Hence, the endogenous chromatinization status known to occur in integrated or genomic vs. episomic DNA might be critical for proper regulation of FasL expression by cAMP and GCs. Our results suggest that the chromatinization status of the FasL promoter may function as a molecular switch, controlling cAMP and GC responsiveness and explaining why these agents inhibit FasL expression in T cells but induce FasL in other cell types. © 2012 Elsevier Ltd. Fil:Liberman, A.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Refojo, D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2012 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01615890_v50_n4_p220_Liberman http://hdl.handle.net/20.500.12110/paper_01615890_v50_n4_p220_Liberman
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Activation-induced cell death
CAMP
Chromatin
FasL
Glucocorticoids
NF-κB
cyclic AMP
cyclic AMP dependent protein kinase
dexamethasone
Fas ligand
genomic DNA
glucocorticoid
immunoglobulin enhancer binding protein
mitogen activated protein kinase
T lymphocyte receptor
animal cell
article
cell death
mouse
nonhuman
priority journal
protein expression
signal transduction
transient transfection
Animals
Apoptosis
Blotting, Western
Cell Death
Cell Separation
Cyclic AMP
Fas Ligand Protein
Flow Cytometry
Glucocorticoids
Humans
Hybridomas
Jurkat Cells
Lymphocyte Activation
Mice
Promoter Regions, Genetic
Receptors, Antigen, T-Cell
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transfection
spellingShingle Activation-induced cell death
CAMP
Chromatin
FasL
Glucocorticoids
NF-κB
cyclic AMP
cyclic AMP dependent protein kinase
dexamethasone
Fas ligand
genomic DNA
glucocorticoid
immunoglobulin enhancer binding protein
mitogen activated protein kinase
T lymphocyte receptor
animal cell
article
cell death
mouse
nonhuman
priority journal
protein expression
signal transduction
transient transfection
Animals
Apoptosis
Blotting, Western
Cell Death
Cell Separation
Cyclic AMP
Fas Ligand Protein
Flow Cytometry
Glucocorticoids
Humans
Hybridomas
Jurkat Cells
Lymphocyte Activation
Mice
Promoter Regions, Genetic
Receptors, Antigen, T-Cell
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transfection
Liberman, Ana
Refojo, Damián
Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
topic_facet Activation-induced cell death
CAMP
Chromatin
FasL
Glucocorticoids
NF-κB
cyclic AMP
cyclic AMP dependent protein kinase
dexamethasone
Fas ligand
genomic DNA
glucocorticoid
immunoglobulin enhancer binding protein
mitogen activated protein kinase
T lymphocyte receptor
animal cell
article
cell death
mouse
nonhuman
priority journal
protein expression
signal transduction
transient transfection
Animals
Apoptosis
Blotting, Western
Cell Death
Cell Separation
Cyclic AMP
Fas Ligand Protein
Flow Cytometry
Glucocorticoids
Humans
Hybridomas
Jurkat Cells
Lymphocyte Activation
Mice
Promoter Regions, Genetic
Receptors, Antigen, T-Cell
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transfection
description Glucocorticoids (GCs) and cAMP-dependent signaling pathways exert diverse and relevant immune regulatory functions, including a tight control of T cell death and homeostasis. Both of these signaling molecules inhibit TCR-induced cell death and FasL expression, but the underlying mechanisms are still poorly understood. Therefore, to address this question, we performed a comprehensive screening of signaling pathways downstream of the TCR, in order to define which of them are targets of cAMP- and GC-mediated inhibition. We found that cAMP inhibited NF-κB and ERK pathways through a PKA-dependent mechanism, while Dexamethasone blocked TCR-induced NF-κB signaling. Although GCs and cAMP inhibited the induction of endogenous FasL mRNA expression triggered by TCR activation, they potentiated TCR-mediated induction of FasL promoter activity in transient transfection assays. However, when the same FasL promoter was stably transfected, the facilitatory effect of GCs and cAMP became inhibitory, thus resembling the effects on endogenous FasL mRNA expression. Hence, the endogenous chromatinization status known to occur in integrated or genomic vs. episomic DNA might be critical for proper regulation of FasL expression by cAMP and GCs. Our results suggest that the chromatinization status of the FasL promoter may function as a molecular switch, controlling cAMP and GC responsiveness and explaining why these agents inhibit FasL expression in T cells but induce FasL in other cell types. © 2012 Elsevier Ltd.
author Liberman, Ana
Refojo, Damián
author_facet Liberman, Ana
Refojo, Damián
author_sort Liberman, Ana
title Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
title_short Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
title_full Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
title_fullStr Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
title_full_unstemmed Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death
title_sort underlying mechanisms of camp- and glucocorticoid-mediated inhibition of fasl expression in activation-induced cell death
publishDate 2012
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01615890_v50_n4_p220_Liberman
http://hdl.handle.net/20.500.12110/paper_01615890_v50_n4_p220_Liberman
work_keys_str_mv AT libermanana underlyingmechanismsofcampandglucocorticoidmediatedinhibitionoffaslexpressioninactivationinducedcelldeath
AT refojodamian underlyingmechanismsofcampandglucocorticoidmediatedinhibitionoffaslexpressioninactivationinducedcelldeath
_version_ 1768544681270968320